期刊文献+

严重急性呼吸综合征肺纤维化的病理过程初步研究 被引量:2

Pathologic process of pulmonary fibrosis in severe acute respiratory syndrome:a preliminary report
原文传递
导出
摘要 目的:探讨不同时间SAILS死亡患者肺纤维化的病变经历过程及特点。方法:以6例SAILS死亡患者(分别于发病后9,14,20,29,33。38d死亡)肺标本为对象,应用常规HE染色、三联染色、苦味酸-天狼猩红-偏振光法和电镜等技术方法,观察SARS肺组织的病理变化和纤维化的病理过程以及胶原纤维、网状纤维和弹力纤维的变化特点、Ⅰ型与Ⅲ型胶原纤维分布规律及其超微结构变化。结果:SARS发病后于9—38d死亡的6例患者肺脏出现程度不等的成纤维细胞变化和纤维组织增生,其中2例(33,38d)发生典型的肺纤维化病变。肺间质组织和成纤维细胞变化可大致分为4种类型:成纤维细胞轻度活跃型,见于9,14d死亡例;成纤维细胞增生型,见于20d死亡例;纤维组织增生型,见于29d死亡例;纤维化形成型,见于33,38d死亡例。经三联染色和天狼猩红染色证实,纤维增生以胶原为主,其中Ⅰ型胶原增生较Ⅲ型胶原明显。结论:初步认为,肺脏4种类型病变本质上反映了SARS肺纤维化的发生发展过程,可能经历4个阶段,即:成纤维细胞轻度活跃期、成纤维细胞增生期、纤维组织增生期和纤维化形成期。SARS肺纤维化病变特点为:(1)纤维化出现较早(33d);(2)纤维化病变呈进行性发展;(3)以Ⅰ型胶原纤维为主:(4)局灶性分布突出。 Objective: To explore the pathologic process and characteristics of pulmonary fibrosis of severe acute respiratory syndrome(SARS) patients who died in different periods of time. Methods: The lung preparations of 6 SARS death patients ( died on days 9, 14, 20, 29, 33 and 38) were used as the study objects. Pathological changes, collagen fibers, lattice fibers, elastic fibers, collagen types Ⅰ and Ⅲ in lungs and fine structure changes were studied by routine HE staining, trigeminy staining, trinitropbenol-sirius red staining and polarization microscopy and electron microscopy. Results: The lungs of 6 SARS death patients ( died on days 9 - 38 ) had different degrees of fibroblast changes and fibroplasia, which developed to typical pulmonary fibrosis on days d 33 and 38 in 2 cases. Basic processes of SARS pulmonary fibrosis could be classified into 4 types: fibroblast low-degree active stage (on days 9 -14), fibroblast proliferation stage (on d 20), fibrous tissue proliferation stage (on d 29), and fibrosis emerge stage (on days 33 -38). Collagen fibers were the major component in fibrous proliferation. Collagen type- Ⅰ was more obvious than collagen type-Ⅲ. Condusion :The basic processes of SARS pulmonary fibrosis go through possibly four stages: fibroblast low-degree active stage, fibroblast proliferation stage, cfibrous tissue prohferation, stage, and fibrosis emerge stage. The features of SARS pulmonary fibrosis are as follows: ( 1 ) Fibrosis appeared early ( on d 33). (2) Fibrosis changes develope progressively. ( 3 ) Collagen type- Ⅰ is more obvious than collagen type-Ⅲ. (4)Focal distribution is outstanding.
出处 《军事医学科学院院刊》 CSCD 北大核心 2006年第6期501-504,共4页 Bulletin of the Academy of Military Medical Sciences
基金 国家自然科学基金专项资助课题(30340023) 总后SARS防治研究指令性课题(03F016-1)
关键词 严重急性呼吸综合征(SARS) 肺纤维化 病理过程 SARS i pulmonary fibrosis pathologic process
  • 相关文献

参考文献4

二级参考文献5

共引文献33

同被引文献14

  • 1郝小惠,张丽,王献华.胶原与肺间质纤维化的研究进展[J].华北煤炭医学院学报,2005,7(1):43-45. 被引量:13
  • 2孔琪,秦川.SARS肺纤维化发病机制的比较医学研究[J].中国比较医学杂志,2005,15(6):335-338. 被引量:6
  • 3关东升,王晶,司小兵,陈淑彦,刘世琼.贴敷“咳喘宁”贴膏对支气管哮喘模型大鼠肺泡灌洗液中炎性细胞的影响[J].中医儿科杂志,2006,2(2):15-18. 被引量:9
  • 4GURUJEYALAKSHMI G,WANG Y,GIRI S N. Suppression of bleomycin-induced nitric oxide production in mice by taurine and niacin[J].Nitric Oxide:Biology and Chemistry,2000,(04):399-411.
  • 5SANTOS P S,CAMP(E)LO L M,FREITAS R L. Lipoic acid effects on glutamate and taurine concentrations in rat hippocampus after pilocarpine-induced seizures[J].Arquivos de Neuro-Psiquiatria,2011,(2B):360-364.
  • 6高春芳;陆论根.纤维化疾病的基础和临床[M]上海:上海科学技术出版社,2004439-446.
  • 7LO RE S,LECOCQ M,UWAMBAYINEMA F. Platelet-derived growth factor-producing CD4 + Foxp3 + regulatory T lymphocytes promote lung fibrosis[J].American Journal of Respiratory and Critical Care Medicine,2011,(11):1270-1281.
  • 8HUAUX F,LIU T,MCGARRY B. Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis[J].Journal of Immunology,2003,(10):5470-5481.
  • 9PARK E,JIA J,QUINN M R. Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes[J].Clinical Immunology,2002,(02):179-184.doi:10.1006/clim.2001.5160.
  • 10GURUJEYALAKSHMI G,WANG Y,GIRI S N. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice[J].Journal of Pharmacology and Experimental Therapeutics,2000,(01):82-90.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部